{"id":"W4319308236","doi":"10.1212/wnl.0000000000005345","title":"Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis","year":2018,"lang":"en","type":"review","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"American Academy of Neurology","keywords":"Glatiramer acetate; Medicine; Teriflunomide; Multiple sclerosis; Alemtuzumab; Ocrelizumab; Placebo; Systematic review; Adverse effect; Internal medicine; Natalizumab; Cladribine; Cochrane Library; Expanded Disability Status Scale; Oncology; Disease; MEDLINE; Randomized controlled trial; Fingolimod; Alternative medicine; Immunology; Pathology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003845909,0.0008790244,0.006326471,0.0002917007,0.0002676083,0.0000322463,0.0004856383,0.0002821633,0.00003078908],"category_scores_gemma":[0.002103073,0.0005288396,0.0009805851,0.0003945246,0.0005297754,0.00006311887,0.0002595995,0.0006505629,0.0001076372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007677152,"about_ca_system_score_gemma":0.0003092808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002690307,"about_ca_topic_score_gemma":0.00003291578,"domain_scores_codex":[0.9952904,0.0009164313,0.001163551,0.0011773,0.0005963042,0.0008560244],"domain_scores_gemma":[0.9934216,0.003304414,0.0007445976,0.001389169,0.0007581699,0.0003820655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0008476253,0.0001086053,0.00003072373,0.9752563,0.001264769,0.00004046673,0.00006044016,7.335665e-8,6.139293e-7,0.000003903569,0.0041253,0.01826123],"study_design_scores_gemma":[0.001341985,0.001491844,0.0001085285,0.591812,0.004910691,0.00005478637,0.000008238564,0.00003770988,1.106765e-7,0.000001387836,0.3999286,0.0003041552],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000306839,0.9790345,0.00003026666,0.0007352723,0.0002014251,0.01944249,0.0003323212,0.0001531153,0.0000399188],"genre_scores_gemma":[0.00005929974,0.9872813,0.0002605703,0.002418175,0.0003683207,0.008966552,0.0003602643,0.0001968581,0.00008870062],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3958033,"threshold_uncertainty_score":0.9997163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1591513686219583,"score_gpt":0.3659889685661996,"score_spread":0.2068375999442413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}